@prefix np: . @prefix npx: . @prefix ns1: . @prefix ns2: . @prefix ns3: . @prefix orcid: . @prefix prov: . @prefix rdf: . @prefix rdfs: . @prefix sub: . @prefix this: . @prefix xsd: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { ns3:consider . } sub:provenance { sub:_assertion prov:wasGeneratedBy "S&T TWOC Project - version 4", "S&T TWOC version 3" . sub:_version prov:value "2"^^xsd:integer . sub:assertion prov:generatedAtTime "2023-07-20T09:47:29.237066"^^xsd:dateTime; prov:wasAttributedTo orcid:0000-0003-4692-1377; prov:wasDerivedFrom . rdf:OBJECT rdfs:label "in case of ARDS" . rdf:OBJECT-POSITION rdfs:label "(0, 13)" . rdf:PREDICATE rdfs:label "considered" . rdf:PREDICATE-POSITION rdfs:label "35" . rdf:SUBJECT rdfs:label "Dexamethasone and tocilizumab" . rdf:SUBJECT-POSITION rdfs:label "(0, 13)" . rdf:Statement rdfs:label "Dexamethasone and tocilizumab were considered in case of ARDS." . rdfs:ABSTRACT-UID ns1:50 "esjmr1is" . rdfs:TRIPLE-UID ns2:esjmr1is-TRIPLE-ABSTRACT-1 "esjmr1is-TRIPLE-ABSTRACT-1" . rdfs:label "dexamethasone" . rdfs:label "case" . } sub:pubinfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "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"; npx:hasSignature "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"; npx:hasSignatureTarget this: . this: prov:wasAttributedTo orcid:0000-0003-4692-1377 . }